Jerry Spivak, MD, Johns Hopkins University School of Medicine, Baltimore, MD, shares his thoughts on the importance of improving diagnosis in myeloproliferative neoplasms (MPNs) and further comments on how treatment approaches should be tailored to different subgroups of patients. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.